Noema Pharma
Biotech company targeting debilitating central nervous system (CNS) disorders
Noema Pharma has raised €134M across 2 funding rounds from 7 investors, most recently a Series B round in Dec 2024. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandnoemapharma.com ↗
Total raised
€134M
€134,111,237
Funding rounds
2
Investors
7
distinct backers
Active since
2023-03
latest 2024-12
Funding by year
EUR raised per yearNoema Pharma — funding by year — interactive chart.
Data table
| Noema Pharma — funding by year | |
|---|---|
| 2023 | €105M |
| 2024 | €29M |
Signals
High confidenceRaise-next likelihood55
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Down/flat last round
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-11 | Series B | €29M | Forbion,Gilde Healthcare,Invus,Jeito Capital,Polaris Partners,Sofinnova Partners+1 more | View deal → |
| 2023-03-07 | Series B | €105M | Forbion,Gilde Healthcare,Invus,Jeito Capital,Polaris Partners,Sofinnova Partners+1 more | View deal → |
Investors
7Related news
- Noema Pharma Raises USD112M in Series B Financingfinsmes.com · 2023-03
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData